• Cagrilintide (2.5mg) / GLP-1 (2.5mg) 2ml Vial
1 1

Cagrilintide (2.5mg) / GLP-1 (2.5mg) 2ml Vial

Cagrilintide (2.5mg) / GLP-1 (2.5mg) 2ml Vial

As low as $100 each!
$125.00
$125.00
Sale Sold out
Shipping calculated at checkout.
  • FREE SHIPPING
  • 99+% PURITY
  • MADE IN USA
View full details

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

What is Cagrilintide (2.5mg) / GLP-1 (2.5mg) 2ml Vial?

This dual-peptide formulation combines Cagrilintide, a long-acting amylin analog, with a GLP-1 receptor agonist, creating a synergistic compound designed to support appetite suppression, gastric emptying delay, and metabolic regulation. This blend mimics and amplifies the body’s natural satiety signals, making it a strong research candidate in the field of obesity, type 2 diabetes, and weight loss.

  • Cagrilintide works by activating amylin receptors in the brain, which regulate meal size and fullness.
  • GLP-1 analogs enhance insulin secretion, reduce glucagon, and delay gastric emptying. Together, they create a powerful combination that supports a multi-pathway approach to appetite control and metabolic health.

Chemical Structure of Cagrilintide (2.5mg) / GLP-1 (2.5mg) 2ml Vial

This blend contains two distinct peptides:

  • Cagrilintide: Modified amylin analog with prolonged half-life via fatty acid acylation.
  • GLP-1 analog: Glucagon-like peptide-1 receptor agonist with extended duration.

These peptides act through different receptor systems but complement each other by targeting overlapping metabolic and gastrointestinal pathways.

What Are the Effects of Cagrilintide (2.5mg) / GLP-1 (2.5mg) 2ml Vial?

Appetite Suppression and Satiety Enhancement

Cagrilintide and GLP-1 both promote a prolonged feeling of fullness by acting on the hypothalamus and gastrointestinal tract. This effect supports reduced caloric intake and long-term weight management.

Improved Glycemic Control

GLP-1 analogs have been shown to increase insulin secretion in a glucose-dependent manner, while reducing glucagon release and improving insulin sensitivity—making this blend highly relevant for type 2 diabetes research.

Delay in Gastric Emptying

Both peptides slow the rate of gastric emptying, helping control postprandial glucose spikes and increasing the duration of satiety after meals.

Synergistic Weight Loss Potential

Clinical studies have shown that combining amylin and GLP-1 receptor agonists produces superior weight loss results compared to either peptide alone, due to their complementary mechanisms.

COA

Certificate of Analysis

HPLC

High Performance Liquid Chromatography

High Quality - 99% Purity Guaranteed

Product Quality Guarantee

We are continuously conducting HPLC test on all of our raw powders as well as finished products to ensure the quality of our products. You can have the product you bought from us tested at any HPLC licensed testing facility and if the results are negative, we will refund the following:
HPLC TEST FEE
$100
PLUS Total amount of the Order + Shipping Fee

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)